Curcumin inhibits melanogenesis in human melanocytes

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 174-179

  Tu, Cai Xia ^a   Lin, Mao ^a   Lu, Shan Shan ^a   Qi, Xiao Yi ^a   Zhang, Rong Xin ^a   Zhang, Yun Ying ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Akt; curcumin; extracellular signal regulated kinase; glycogen synthase kinase 3 ; melanogenesis; p38

Indexed keywords

CURCUMIN; GLYCOGEN SYNTHASE KINASE 3BETA; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOPHENOL MONOOXYGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CURCUMIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MELANINS; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84856238416     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3517     Document Type: Article

References (25)

1. Agar N, Young AR,. 2005. Melanogenesis: a photoprotective response to DNA damage? Mutat Res 571: 121-132. (Pubitemid 40313437)
2. Aggarwal BB, Harikumar KB,. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41: 40-59.
3. Ando H, Itoh A, Mishima Y, et al,. 1995. Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents. J Cell Physiol 163: 608-614.
4. Bellei B, Flori E, Izzo E, et al,. 2008. GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes. Cell Signal 20: 1750-1761.
5. Bellei B, Maresca V, Flori E, et al,. 2010. p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem 285: 7288-7299.
6. Chu CY, Liu YL, Chiu HC, et al,. 2006. Dopamine-induced apoptosis in human melanocytes involves generation of reactive oxygen species. Br J Dermatol 154: 1071-1079.
7. Costin GE, Hearing VJ,. 2007. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J 21: 976-994. (Pubitemid 46495689)
8. Draelos ZD,. 2007. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther 20: 308-313. (Pubitemid 350197161)
9. Hatcher H, Planalp R, Cho J, et al,. 2008. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652.
10. Hemesath TJ, Price ER, Takemoto C, et al,. 1998. MAP kinase links the transcription factor microphthalmia to c-Kit signalling in melanocytes. Nature 391: 298-301. (Pubitemid 28099019)
11. Hodgkinson CA, Moore KJ, Nakayama A, et al,. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74: 395-404. (Pubitemid 23221714)
12. Im SJ, Kim KN, Yun YG, et al,. 2003. Effect of Radix Ginseng and Radix Trichosanthis on the melanogenesis. Biol Pharm Bull 26: 849-853.
13. Kanthraj GR,. 2010. Skin-lightening agents: new chemical and plant extracts-ongoing search for the Holy Grail! Indian J Dermatol Venereol Leprol 76: 3-6.
14. Kim DS, Park SH, Kwon SB, et al,. 2006. Sphingosylphosphorylcholine- induced ERK activation inhibits melanin synthesis in human melanocytes. Pigment Cell Res 19: 146-153.
15. Kim DS, Park SH, Kwon SB, et al,. 2007. Additive effects of heat and p38 MAPK inhibitor treatment on melanin synthesis. Arch Pharm Res 30: 581-586.
16. Lee JH, Jang JY, Park C, et al,. 2010. Curcumin suppresses alpha-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells. Int J Mol Med 26: 101-106.
17. Lin JK,. 2007. Molecular targets of curcumin. Adv Exp Med Biol 595: 227-243.
18. Oka M, Ichihashi M, Chakraborty AK,. 1996. Enhanced expression of protein kinase C subspecies in melanogenic compartments in B16 melanoma cells by UVB or MSH. J Invest Dermatol 106: 377-378. (Pubitemid 26094626)
19. Oka M, Kageyama A, Fukunaga M, et al,. 2004. Phosphatidylinositol 3-kinase/Akt-dependent and -independent protection against apoptosis in normal human melanocytes. J Invest Dermatol 123: 930-936. (Pubitemid 39391940)
20. Oka M, Nagai H, Ando H, et al,. 2000. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J Invest Dermatol 115: 699-703.
21. Olivares C, Solano F,. 2009. New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins. Pigment Cell Melanoma Res 22: 750-760.
22. Park ES, Kim SY, Na JI, et al,. 2007. Glutathione prevented dopamine-induced apoptosis of melanocytes and its signaling. J Dermatol Sci 47: 141-149.
23. Singh SK, Sarkar C, Mallick S, et al,. 2005. Human placental lipid induces melanogenesis through p38 MAPK in B16F10 mouse melanoma. Pigment Cell Res 18: 113-121. (Pubitemid 40445047)
24. Steingrimsson E, Moore KJ, Lamoreux ML, et al,. 1994. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 8: 256-263. (Pubitemid 24338737)
25. Takeda K, Takemoto C, Kobayashi I, et al,. 2000. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet 9: 125-132. (Pubitemid 30145297)